Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04916691 · ClinicalTrials.gov registry record · Early Phase 1
Ultrasound-guided Erector Spinae Plane Blocks
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT04916691: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT04916691 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04916691, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of using the ultrasound-guided erector spinae plane blocks to provide additional pain relief to patients with rib fractures in the Emergency Department (ED) and Intensive Care Unit (ICU).
Interventions
- DRUG Ropivacaine
- PROCEDURE EPSB for rib fractures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-05-15 |
| Est. Completion | 2022-08-22 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04916691
The ClinicalTrials.gov registry entry for NCT04916691 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine is the first listed.
NCT04916691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04916691 about?
NCT04916691 is a clinical study titled "Ultrasound-guided Erector Spinae Plane Blocks". The purpose of this study is to determine the feasibility of using the ultrasound-guided erector spinae plane blocks to provide additional pain relief to patients with rib fractures in the Emergency Department (ED) and Intensive Care Unit (ICU).
What is the current status of trial NCT04916691?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2021-05-15. Estimated completion is 2022-08-22.
What interventions are being tested in trial NCT04916691?
The interventions under investigation include: Ropivacaine (DRUG), EPSB for rib fractures (PROCEDURE).
Who is sponsoring clinical trial NCT04916691?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.